Amarin Tells Justices Hikma Drug Patent Appeal Threatens IP
By Ryan Davis · March 23, 2026, 9:22 PM EDT
Amarin Pharma Inc. has urged the U.S. Supreme Court to uphold a decision that it plausibly alleged that generics maker Hikma Pharmaceuticals USA Inc. encouraged infringement of patents on the heart...
To view the full article, register now.